Citation

Prakash S, Mandal P, Sagar R. J. Pharmacol. Pharmacother. 2013; 4(4): 288-290.

Copyright

(Copyright © 2013, Medknow Publications)

DOI

10.4103/0976-500X.119718

PMID

unavailable

Abstract

Recurrent brief depressive disorder is now a well-recognized type of depressive disorder. However, there is still no clear evidence base for its treatment. The efficacy of several drugs including antidepressants and mood stabilizers in this disorder has been controversial.

METHODological limitations need to be considered when interpreting the results of studies on efficacy of drugs in this disorder. We report a case of recurrent brief depressive disorder that responded dramatically to paroxetine. However, there is a need for larger, methodologically sound, double-blind, placebo-controlled studies.

Language: en

Keywords

adult; human; female; case report; suicidal ideation; suicide attempt; Antidepressants; mood disorder; hopelessness; fatigue; article; mirtazapine; paroxetine; sleep disorder; follow up; self esteem; Hamilton scale; patient counseling; escitalopram; public figure; drug response; concentration loss; anhedonia; mood stabilizers; drug dose increase; job stress; treatment duration; work resumption; decreased appetite; recurrent brief depression